Is There Already a Need of Reckoning on Cancer Immunotherapy?

• Pierpaolo Correale,
• Francesca Pentimalli,
• Giovanni Baglio,
• Marjia Krstic-Demonacos,
• Rita Emilena Saladino,
• Antonio Giordano,
• Antonio Giordano,
• Luciano Mutti

Affiliations

Pierpaolo Correale

Unit of Medical Oncology, Oncology Department, Grand Metropolitan Hospital ‘Bianchi Melacrino Morelli’, Reggio Calabria, Italy

Francesca Pentimalli

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy

Giovanni Baglio

Sbarro Institute for Cancer Research and Molecular Medicine, Philadelphia, PA, United States

Marjia Krstic-Demonacos

Biomedical Research Center, School of Science, Engineering and Environment, University of Salford, Salford, United Kingdom

Rita Emilena Saladino

Tissue Typing Unit, Grand Metropolitan Hospital ‘Bianchi Melacrino Morelli’, Reggio Calabria, Italy

Antonio Giordano

Department of Medical Biotechnologies, University of Siena, Siena, Italy

Antonio Giordano

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, United States

Luciano Mutti

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, United States